𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs

✍ Scribed by Mosis, Georgio ;Stijnen, Theo ;Castellsague, Jordi ;Dieleman, Jeanne P. ;van der Lei, Johan ;Stricker, Bruno H. C. ;Sturkenboom, Miriam C. J. M.

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
81 KB
Volume
55
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Simultaneous assessment of short-term ga
Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: An instrumental variable analysis
✍ Sebastian Schneeweiss; Daniel H. Solomon; Philip S. Wang; Jeremy Rassen; M. Alan πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 2 views

## Abstract ## Objective To simultaneously assess the short‐term reduction in risk of gastrointestinal (GI) complications and increase in risk of acute myocardial infarction (MI) by celecoxib compared with rofecoxib and several nonselective nonsteroidal antiinflammatory drugs (NSAIDs) using instru

Risk of congestive heart failure with no
Risk of congestive heart failure with nonsteroidal antiinflammatory drugs and selective Cyclooxygenase 2 inhibitors: A class effect?
✍ Hudson, Marie ;Rahme, Elham ;Richard, Hugues ;Pilote, Louise πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 2 views

## Abstract ## Objective Nonsteroidal antiinflammatory drugs (NSAIDs) as a class have been shown to increase the risk of congestive heart failure (CHF) compared with celecoxib. The magnitude of the risk for individual NSAIDs is not known. ## Methods Using administrative databases, we performed a